• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

母亲感染 SARS-CoV-2 后所生婴儿粪便中 SARS-CoV-2 的排出:一项初步研究。

Fecal shedding of SARS-CoV-2 in infants born to SARS-CoV-2 positive mothers: a pilot study.

机构信息

Department of Food Science and Technology, University of California, Davis, CA, United States of America.

Department of Pediatrics, University of California, Davis, Sacramento, CA, United States of America.

出版信息

PeerJ. 2024 Aug 27;12:e17956. doi: 10.7717/peerj.17956. eCollection 2024.

DOI:10.7717/peerj.17956
PMID:39221275
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11363909/
Abstract

BACKGROUND

Fecal shedding of SARS-CoV-2 occurs during infection, particularly in pediatric populations. The gut microbiota are associated with resistance to enteric pathogens. COVID-19 is associated with alterations to the gut microbiome. We hypothesized that the gut microbiome of infants born to SARS-CoV-2+ mothers differs between infants with and without fecal shedding of the virus.

METHODS

We enrolled 10 infants born to SARS-CoV-2+ mothers. We used qPCR on fecal RNA to test for SARS-CoV-2 and 16S rRNA gene sequencing of the V4 region to assess the gut microbiome. Infant SARS-CoV-2 status from nasal swabs was abstracted from medical records.

RESULTS

Of the 10 included infants, nine were tested for SARS-CoV-2 by nasal swab with 1 testing positive. Four infants, including the nasal swab positive infant, had at least one sample with detectable levels of SARS-CoV-2 fecal shedding. Detection of both SARS-CoV-2 genes in feces was associated with increased gut alpha diversity compared to no detection by a linear mixed effects model ( < 0.001). Detection of both SARS-CoV-2 genes was associated with increased levels Erysipelotrichaceae, Lactobacillaceae, and Ruminococceae by MaAsLin2.

CONCLUSION

Fecal shedding of SARS-CoV-2 occurs in infants who test negative on nasal swabs and is associated with differences in the gut microbiome.

摘要

背景

SARS-CoV-2 在感染期间会从粪便中排出,尤其是在儿科人群中。肠道微生物群与抵抗肠道病原体有关。COVID-19 与肠道微生物组的改变有关。我们假设,SARS-CoV-2+母亲所生婴儿的肠道微生物组在粪便中是否有病毒排出的婴儿之间存在差异。

方法

我们招募了 10 名 SARS-CoV-2+母亲所生的婴儿。我们使用粪便 RNA 的 qPCR 检测 SARS-CoV-2 和 V4 区的 16S rRNA 基因测序来评估肠道微生物组。从病历中提取婴儿鼻拭子中的 SARS-CoV-2 状态。

结果

在 10 名纳入的婴儿中,有 9 名通过鼻拭子进行了 SARS-CoV-2 检测,其中 1 名检测结果阳性。4 名婴儿,包括鼻拭子阳性婴儿,至少有一个样本中可检测到 SARS-CoV-2 的粪便排出。线性混合效应模型显示,粪便中同时检测到两种 SARS-CoV-2 基因与较高的肠道 α 多样性相关(<0.001)。通过 MaAsLin2 检测到两种 SARS-CoV-2 基因与肠杆菌科、乳杆菌科和真杆菌科水平的升高相关。

结论

在鼻拭子检测为阴性的婴儿中会出现 SARS-CoV-2 的粪便排出,且与肠道微生物组的差异有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfb4/11363909/e1cb8ce51d20/peerj-12-17956-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfb4/11363909/cf718f46f634/peerj-12-17956-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfb4/11363909/a8549cd29354/peerj-12-17956-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfb4/11363909/535c16b42533/peerj-12-17956-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfb4/11363909/e1cb8ce51d20/peerj-12-17956-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfb4/11363909/cf718f46f634/peerj-12-17956-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfb4/11363909/a8549cd29354/peerj-12-17956-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfb4/11363909/535c16b42533/peerj-12-17956-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfb4/11363909/e1cb8ce51d20/peerj-12-17956-g004.jpg

相似文献

1
Fecal shedding of SARS-CoV-2 in infants born to SARS-CoV-2 positive mothers: a pilot study.母亲感染 SARS-CoV-2 后所生婴儿粪便中 SARS-CoV-2 的排出:一项初步研究。
PeerJ. 2024 Aug 27;12:e17956. doi: 10.7717/peerj.17956. eCollection 2024.
2
Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization.COVID-19 患者住院期间肠道微生物组的变化。
Gastroenterology. 2020 Sep;159(3):944-955.e8. doi: 10.1053/j.gastro.2020.05.048. Epub 2020 May 20.
3
Gut virome and microbiome dynamics before and after SARS-CoV-2 infection in women living with HIV and their infants.女性 HIV 感染者及其婴儿在感染 SARS-CoV-2 前后的肠道病毒组和微生物组动态。
Gut Microbes. 2024 Jan-Dec;16(1):2394248. doi: 10.1080/19490976.2024.2394248. Epub 2024 Aug 26.
4
The gut microbiome of COVID-19 recovered patients returns to uninfected status in a minority-dominated United States cohort.少数族群为主的美国队列中,COVID-19 康复患者的肠道微生物组恢复到未感染状态。
Gut Microbes. 2021 Jan-Dec;13(1):1-15. doi: 10.1080/19490976.2021.1926840.
5
The Entero-Mammary Pathway and Perinatal Transmission of Gut Microbiota and SARS-CoV-2.肠-乳腺途径与肠道微生物群和 SARS-CoV-2 的围产期传播。
Int J Mol Sci. 2022 Sep 7;23(18):10306. doi: 10.3390/ijms231810306.
6
Prevalence and duration of SARS-CoV-2 fecal shedding in breastfeeding dyads following maternal COVID-19 diagnosis.COVID-19 母亲确诊后母乳喂养母婴对 SARS-CoV-2 粪便脱落的流行和持续时间。
Front Immunol. 2024 Mar 21;15:1329092. doi: 10.3389/fimmu.2024.1329092. eCollection 2024.
7
Breast Milk and Breastfeeding of Infants Born to SARS-CoV-2 Positive Mothers: A Prospective Observational Cohort Study.SARS-CoV-2 阳性母亲所生婴儿的母乳和母乳喂养:一项前瞻性观察队列研究。
Am J Perinatol. 2021 Sep;38(11):1209-1216. doi: 10.1055/s-0041-1731451. Epub 2021 Jun 28.
8
SARS-CoV-2 in infant urine and fecal samples after in utero COVID-19 exposure.胎儿感染新冠病毒后,婴儿尿液和粪便样本中存在 SARS-CoV-2。
Pediatr Res. 2022 Aug;92(2):536-540. doi: 10.1038/s41390-021-01822-x. Epub 2021 Oct 30.
9
Detection of SARS-CoV-2 in Fecal Samples From Patients With Asymptomatic and Mild COVID-19 in Korea.韩国无症状和轻症 COVID-19 患者粪便样本中 SARS-CoV-2 的检测。
Clin Gastroenterol Hepatol. 2021 Jul;19(7):1387-1394.e2. doi: 10.1016/j.cgh.2020.06.005. Epub 2020 Jun 10.
10
Altered oral and gut microbiota and its association with SARS-CoV-2 viral load in COVID-19 patients during hospitalization.住院 COVID-19 患者中肠道和口腔微生物群的改变及其与 SARS-CoV-2 病毒载量的关系。
NPJ Biofilms Microbiomes. 2021 Jul 22;7(1):61. doi: 10.1038/s41522-021-00232-5.

本文引用的文献

1
Prevalence and duration of SARS-CoV-2 fecal shedding in breastfeeding dyads following maternal COVID-19 diagnosis.COVID-19 母亲确诊后母乳喂养母婴对 SARS-CoV-2 粪便脱落的流行和持续时间。
Front Immunol. 2024 Mar 21;15:1329092. doi: 10.3389/fimmu.2024.1329092. eCollection 2024.
2
Microbial and immune faecal determinants in infants hospitalized with COVID-19 reflect bifidobacterial dysbiosis and immature intestinal immunity.COVID-19 住院患儿粪便中的微生物和免疫决定因素反映了双歧杆菌失调和不成熟的肠道免疫。
Eur J Pediatr. 2023 Oct;182(10):4633-4645. doi: 10.1007/s00431-023-05140-8. Epub 2023 Aug 9.
3
The microbiota of pregnant women with SARS-CoV-2 and their infants.
孕妇及其婴儿的 SARS-CoV-2 微生物群。
Microbiome. 2023 Jun 26;11(1):141. doi: 10.1186/s40168-023-01577-z.
4
Variant-specific SARS-CoV-2 shedding rates in wastewater.污水中具有变异特异性的 SARS-CoV-2 脱落率。
Sci Total Environ. 2023 Jan 20;857(Pt 1):159165. doi: 10.1016/j.scitotenv.2022.159165. Epub 2022 Oct 3.
5
The Relationship Between Pediatric Gut Microbiota and SARS-CoV-2 Infection.儿科肠道微生物群与 SARS-CoV-2 感染的关系。
Front Cell Infect Microbiol. 2022 Jul 8;12:908492. doi: 10.3389/fcimb.2022.908492. eCollection 2022.
6
The relationship between the gut microbiome and the risk of respiratory infections among newborns.新生儿肠道微生物群与呼吸道感染风险之间的关系。
Commun Med (Lond). 2022 Jul 14;2:87. doi: 10.1038/s43856-022-00152-1. eCollection 2022.
7
Effect of age on human ACE2 and ACE2-expressing alveolar type II cells levels.年龄对人血管紧张素转换酶 2(ACE2)和 ACE2 表达的肺泡Ⅱ型细胞水平的影响。
Pediatr Res. 2023 Mar;93(4):948-952. doi: 10.1038/s41390-022-02163-z. Epub 2022 Jun 23.
8
Microbiome Modulation as a Novel Strategy to Treat and Prevent Respiratory Infections.微生物群调节作为治疗和预防呼吸道感染的新策略
Antibiotics (Basel). 2022 Apr 1;11(4):474. doi: 10.3390/antibiotics11040474.
9
Gastrointestinal symptoms and fecal shedding of SARS-CoV-2 RNA suggest prolonged gastrointestinal infection.胃肠道症状和 SARS-CoV-2 RNA 的粪便脱落表明胃肠道感染时间延长。
Med. 2022 Jun 10;3(6):371-387.e9. doi: 10.1016/j.medj.2022.04.001. Epub 2022 Apr 13.
10
Prolonged rectal shedding of SARS-CoV-2 in a 22-day-old-neonate: a case report.22 天大的新生儿持续直肠排出 SARS-CoV-2:病例报告。
BMC Pediatr. 2021 Nov 12;21(1):506. doi: 10.1186/s12887-021-02976-7.